Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug 30;16(1):325.
doi: 10.1186/s12906-016-1327-2.

Investigation of the Immunomodulatory effect of Berberis vulgaris on core-pulsed dendritic cell vaccine

Affiliations

Investigation of the Immunomodulatory effect of Berberis vulgaris on core-pulsed dendritic cell vaccine

Doaa A Ghareeb et al. BMC Complement Altern Med. .

Abstract

Background: Virus-induced dendritic cells (DCs) functional deficiency leads to sub-optimal initiation of adaptive immune responses and consequently chronic infection establishment. The present study reports an advanced hepatitis C virus (HCV) therapeutic vaccine model based on In vivo enrichment of DCs with barberry ethanolic crude extract (BCE) then pulsing them with HCV core protein.

Methods: DCs were enriched by BCE intravenous injection in BALB/c mice. Vaccine efficiency was assessed by flow cytometric analysis of splenocytes of immunized mice, cytokine profiling, cytotoxic T lymphocyte assay, and humoral immune response assessment.

Results: There was no significant difference in surface phenotypic characterization of splenocytes from mice immunized with non-BCE-enriched-core-pulsed DCs (iDcs-core) compared to those from mice injected with RPMI-1640 medium. However, splenocytes from mice immunized with BCE-enriched-core-pulsed DCs showed 197 % increase in CD16+ population, 33 % increase in MHCII(+) population, and 43 % decrease in CD3(+) population. In iDCs-core group, 57.9 % greater anti-core cytotoxic T lymphocyte activity, up-regulation in interferon gamma and interleukin (IL) -12 expression, and down-regulation in IL-4 and IL-10 were recorded. Moreover, sustained specific anti-core antibodies were detected only in sera of the same group.

Conclusions: results indicate that BCE-enriched-core-transduced DCs may serve as a new model for immunotherapy of HCV chronic infection.

Keywords: Berberis vulgaris; IL 12; IL 4; INF-γ; Th-1.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Effect of immunization with different subsets of DCs on surface marker expression in splenocytes of immunized mice. Splenocytes of immunized mice with BCE-induced-core pulsed dendritic cells, in a 3-dose immunization schedule at 4 weeks intervals, shows an elevated CD16+and MHCII+ populations when compared to RPMI - 1640 group. Spleens of immunized mice were dissociated by gentleMACS dissociator, as described in Materials and Methods, into a single-cell suspension. Freshly isolated splenocytes were stained with MHCII-FITC, Fcγ RIII/CD16-APC, and CD3-PE monoclonal antibodies and analyzed by flow cytometry. Data are shown as the percentage of splenocytes bearing surface antigen over total splenocytes population. * indicates a significant difference with RPMI group. Results are means ± SD of splenocytes of six mice. (PRPMI - 1640 group that received complete medium, nDCs group that received non-BCE-induced DC, nDCs-core group that received non-BCE-induced DCs transduced with core protein, iDCs group that received BCE-induced DCs, iDCs-core group that received BCE-induced DCs transduced with core protein)
Fig. 2
Fig. 2
Effect of mice immunization on the expression of splenic INF-γ, IL-12p40, IL-4 and IL-10 respectively. Cytokine profile of splenocytes of mice immunized with BCE-induced-core-pulsed DCs exhibits a great shifting towards up-regulating Th1 cytokine profile and down-regulating Th2 cytokine profile. Specific PCR amplification of reverse-transcribed total RNA (1 μg) from 1 × 106 of splenocytes of mice immunized with different subsets of DCs for 4 weeks
Fig. 3
Fig. 3
Cytolytic protein expression of INF-γ after mice immunization. Mice immunized with iDCs or iDCs-core cells increases intrasplenic IFN-γ production in their splenocytes when compared to RPMI group and/or nDCs and nDCs-core groups. Cytoplasmic contents of cytokines protein expression of INF-γ was assessed from 1 × 106 of splenocytes using ELISA as previously mentioned at material and methods. Data are shown as the percentage of splenocytes bearing surface antigen over total splenocytes population. * indicates a significant difference with RPMI- 1640 group. Results are means ± SD of splenocytes of six mice. # indicates a significant difference within nDCs, and nDCs-core groups
Fig. 4
Fig. 4
Splenocytes of iDCs-core group have a good T lymphocyte suppression capacity only on EL4-core cells. Splenocytes of immunized mice (E) were co-cultured with EL-4 or EL-4-core cells (T) at a ratio of 1:1.6 E:T. EL-4 cells were transduced with core recombinant peptides using BioPORTER quickEase protein delivery Kit as previously described. Co-cultured cells were incubated at 37 °C for 4 h and their cytotoxicity was assessed using MTT viability test and LDH release. Data are shown as the percentage of splenocytes bearing surface antigen over total splenocytes population. * indicates a significant difference with RPMI group. Results are means ± SD of splenocytes of six mice. # indicates a significant difference within nDCs, and nDCs-core groups
Fig. 5
Fig. 5
Antigen-specific IgG antibodies generated in mice by immunization with DCs. Humoral response assessment revealed potent and specific anti-core IgG antibodies (total IgG) only in iDCs-core group. Detection of igG antibody responses to the HCV core protein in immunized mice by ELISA. Pooled sera (1:50 dilution) from each group were incubated in wells coated with recombinant HCV core protein (NS3 protein was used as a negative control) and detected by a goat anti-mouse secondary antibody (immuno- globulin) conjugated to alkaline phosphatase. The results are expressed as the optical densities (O.D.) at 405 nm. * indicates a significant difference among groups. Results are means ± SD of sera of six mice

Similar articles

Cited by

References

    1. Ghany MG, Strader DB, Thomas DL, Seeff LB. American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49(4):1335–1374. doi: 10.1002/hep.22759. - DOI - PMC - PubMed
    1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology (Baltimore, Md) 2013;57(4):1333–1342. doi: 10.1002/hep.26141. - DOI - PubMed
    1. Breban R, Doss W, Esmat G, Elsayed M, Hellard M, Ayscue P, Albert M, Fontanet A, Mohamed MK. Towards realistic estimates of HCV incidence in Egypt. J Viral Hepat. 2013;20(4):294–296. doi: 10.1111/j.1365-2893.2012.01650.x. - DOI - PubMed
    1. Manns MP, Foster GR, Rockstroh JK, Zeuzem S, Zoulim F, Houghton M. The way forward in HCV treatment--finding the right path. Nat Rev Drug Discov. 2007;6(12):991–1000. doi: 10.1038/nrd2411. - DOI - PubMed
    1. Coligan JE, Vogel S. Innate Immunity. In: Coligan JE, Bierer BE, Margulies DH, Shevach EM, Strober W, editors. Current Protocols in Immunology. Hoboken: Wiley; 2012. pp. 1401–1407.

LinkOut - more resources